1. Biochemical consequences of mutations causing the GM2 gangliosidoses;Mahuran;Biochim. Biophys. Acta,1999
2. Hexosaminidase isozyme in type O Gm2 gangliosidosis (Sandhoff–Jatzkewitz disease);Beutler;Am. J. Hum. Genet.,1975
3. Characterization of Hex S, the major residual beta hexosaminidase activity in type O Gm2 gangliosidosis (Sandhoff–Jatzkewitz disease);Ikonne;Am. J. Hum. Genet.,1975
4. Prevalence of lysosomal storage disorders;Meikle;JAMA,1999
5. Sandhoff disease heterozygote detection: a component of population screening for Tay–Sachs disease carriers. II. Sandhoff disease gene frequencies in American Jewish and non-Jewish populations;Cantor;Am. J. Hum. Genet.,1987